{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T01:20:14Z","timestamp":1770427214262,"version":"3.49.0"},"reference-count":42,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,3,6]],"date-time":"2002-03-06T00:00:00Z","timestamp":1015372800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> 2\u2010chlorodeoxyadenosine (2\u2010CdA) and arabinosylcytosine (araC) are nucleoside drugs that are used to treat various leukaemias, although 2\u2010CdA has not been tested extensively in children with acute lymphoblastic leukaemia (ALL). Nucleoside cytotoxicity depends on the conversion of these agents to 5\u2032\u2010phosphate derivatives, following drug entry into cells via nucleoside transport (NT) processes. This study compared <jats:italic>es<\/jats:italic> nucleoside transporter content, determined using a flow cytometric assay with SAENTA [5\u2032\u2010<jats:italic>S\u2010<\/jats:italic>(2\u2010aminoethyl)\u2010<jats:italic>N<\/jats:italic><jats:sup><jats:italic>6<\/jats:italic><\/jats:sup><jats:italic>\u2010<\/jats:italic>(4\u2010nitrobenzyl)\u20105\u2032\u2010thioadenosine] fluorescein, and cytotoxicities of 2\u2010CdA and araC in fresh lymphoblasts from previously untreated paediatric ALL patients and the human T\u2010lymphoblast cell line, CCRF\u2010CEM. Lymphoblast samples from individual patients ranged widely in sensitivity to both 2\u2010CdA (IC<jats:sub>50,<\/jats:sub> 6\u2003nmol\/l to &gt; 5\u2003\u03bcmol\/l; mean = 418\u2003nmol\/l; <jats:italic>n<\/jats:italic> = 8) and araC (IC<jats:sub>50<\/jats:sub>, 59\u2003nmol\/l to &gt; 5\u2003\u03bcmol\/l; mean\u2003=\u20031050\u2003nmol\/l; <jats:italic>n<\/jats:italic>\u2003=\u20037), although IC<jats:sub>50<\/jats:sub> values for the two drugs were correlated (<jats:italic>r<\/jats:italic>\u2003=\u20030\u00b778, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7032, <jats:italic>n<\/jats:italic>\u2003=\u20037). Cellular <jats:italic>es<\/jats:italic> nucleoside transporter content varied more than 35\u2010fold among samples from 10 patients. The correlation between <jats:italic>es<\/jats:italic> nucleoside transporter content and drug sensitivity was statistically significant for araC (<jats:italic>r<\/jats:italic>\u2003=\u2003\u22120\u00b793, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7023, <jats:italic>n<\/jats:italic>\u2003=\u20035), but not for 2\u2010CdA (<jats:italic>r<\/jats:italic>\u2003=\u2003\u22120\u00b757, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b723, <jats:italic>n<\/jats:italic>\u2003=\u20036). Exposure of CCRF\u2010CEM cells to araC resulted in a substantial araC concentration\u2010dependent increase in the relative survival of <jats:italic>es<\/jats:italic> transporter\u2010deficient cells, whereas the increase was slight following exposure to 2\u2010CdA. We conclude that, in ALL lymphoblasts, <jats:italic>es<\/jats:italic> nucleoside transporter content is a determinant of araC sensitivity and that a deficiency in NT may impart resistance to araC.<\/jats:p>","DOI":"10.1046\/j.0007-1048.2001.03300.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:42:44Z","timestamp":1047364964000},"page":"528-537","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cytotoxicity of 2\u2010chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content"],"prefix":"10.1111","volume":"116","author":[{"given":"Adrienne M. P.","family":"Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan R. P.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Sowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Akabutu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Grundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy P.","family":"Gati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,3,6]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"1674","article-title":"Intracellular pharmacokinetics of 2\u2010chlorodeoxyadenosine in leukemia cells from patients with chronic lymphocytic leukemia","volume":"9","author":"Alessi\u2010Severini S.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_3_1","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley M.C.","year":"1988","journal-title":"Cancer Research"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0065-2571(93)90021-5"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/15257779408013276"},{"key":"e_1_2_6_6_1","first-page":"482","article-title":"Stroma\u2010supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs","volume":"7","author":"Campana D.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.7.2232"},{"key":"e_1_2_6_8_1","first-page":"403","volume-title":"Drug Transport in Antimicrobial Therapy and Anticancer Therapy","author":"Cass C.E.","year":"1995"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"9732","DOI":"10.1016\/S0021-9258(19)38732-0","article-title":"Nucleoside transport in L1210 murine leukemia cells","volume":"265","author":"Crawford C.R.","year":"1988","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_6_10_1","first-page":"405","article-title":"Use of SAENTA\u2010fluorescein in a flow cytometric assay of cellular es nucleoside transporter site abundance, a correlate of chemosensitivity to cytarabine in acute myeloid leukemia","volume":"37","author":"Gati W.P.","year":"1996","journal-title":"Proceedings of the American Association for Cancer Research"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.1.346"},{"key":"e_1_2_6_12_1","first-page":"35","article-title":"Es nucleoside transporter content of acute leukemia cells: Role in cell sensitivity to cytarabine (araC)","volume":"32","author":"Gati W.P.","year":"1998","journal-title":"Leukemia and Lymphoma"},{"key":"e_1_2_6_13_1","first-page":"6923","article-title":"Mechanism of inhibition of DNA synthesis by 2\u2010chlorodeoxyadenosine in human lymphoblastic cells","volume":"49","author":"Griffig J.","year":"1989","journal-title":"Cancer Research"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990140107"},{"key":"e_1_2_6_15_1","first-page":"121A","article-title":"Phase II trial of 2\u2010chlorodeoxyadenosine in low grade lymphoma","volume":"74","author":"Kay A.C.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja00333a046"},{"key":"e_1_2_6_17_1","first-page":"1235","article-title":"Pharmacokinetics of cladribine (2\u2010chlorodeoxyadenosine) in children with acute leukemia","volume":"54","author":"Kearns C.M.","year":"1994","journal-title":"Cancer Research"},{"key":"e_1_2_6_18_1","first-page":"577","article-title":"Membrane transport of 2\u2010chloro\u20102\u2032\u2010deoxyadenosine is required for cytotoxicity","volume":"35","author":"King K.E.","year":"1994","journal-title":"Proceedings of the American Association for Cancer Research"},{"key":"e_1_2_6_19_1","first-page":"1864","article-title":"In vitro chemosensitivity assessed with the MTT assay in childhood acute non\u2010lymphoblastic leukemia","volume":"9","author":"Klumper E.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1415.bloodjournal8451415"},{"key":"e_1_2_6_21_1","first-page":"1116","article-title":"Use of stroma\u2010supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2\u2010chloro\u2010deoxyadenosine in acute lymphoblastic leukemia","volume":"8","author":"Kumagai M.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08112.x"},{"key":"e_1_2_6_23_1","first-page":"1701","volume-title":"Principals and Practice of Pediatrics","author":"Mahony D.H.","year":"1994"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930715)72:2<439::AID-CNCR2820720220>3.0.CO;2-4"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1139\/o71-039"},{"key":"e_1_2_6_26_1","first-page":"14","article-title":"Inhibitor\u2010sensitive, Na+\u2010linked transport of nucleoside analogs in leukemia cells from patients","volume":"34","author":"Paterson A.R.P.","year":"1993","journal-title":"Proceedings of the American Association for Cancer Research"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00244a003"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950220502"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood.V79.4.843.bloodjournal794843","article-title":"2\u2010Chlorodeoxyadenosine treatment of lymphoid malignancies","volume":"79","author":"Piro L.D.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.3.1069.bloodjournal7231069"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90733-6"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(92)90022-R"},{"key":"e_1_2_6_33_1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1200\/JCO.1991.9.3.416","article-title":"A Phase I clinical trial of 2\u2010chlorodeoxyadenosine in pediatric patients with acute leukemia","volume":"9","author":"Santana V.M.","year":"1991","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.3.364"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1989.252"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990130216"},{"key":"e_1_2_6_37_1","first-page":"1003","article-title":"Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry","volume":"22","author":"Sutherland D.R.","year":"1994","journal-title":"Experimental Hematology"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112823"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110472"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(83)90029-9"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111741"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401633"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(85)90294-9"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.0007-1048.2001.03300.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.0007-1048.2001.03300.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.0007-1048.2001.03300.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:50:53Z","timestamp":1697424653000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.0007-1048.2001.03300.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1046\/j.0007-1048.2001.03300.x"],"URL":"https:\/\/doi.org\/10.1046\/j.0007-1048.2001.03300.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]},"assertion":[{"value":"2002-03-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}